Whistleblower Allegations Expose Systemic Failures in Organ Procurement

A U.S. House Committee on Ways and Means oversight hearing has brought to light significant concerns regarding the operations of organ procurement organizations (OPOs) across the nation. Whistleblower testimonies presented to the committee detailed allegations of mismanagement, a lack of transparency, and unethical practices within the organ donation system, raising serious questions about patient safety and the integrity of the process. The committee concluded that immediate and comprehensive reforms are essential to strengthen oversight, ensure accountability, and protect the interests of patients and their families.

The hearing, which focused on accountability within OPOs, heard from individuals who have firsthand experience with the system’s shortcomings. These accounts detailed how failures in organ recovery processes can lead to devastating consequences for recipients and their families, ranging from organs not being recovered due to OPO inaccessibility or lack of trained personnel, to breakdowns in testing and documentation irregularities. These systemic issues have been described by some as an “organ procurement crisis,” stemming not only from individual missteps but also from an outdated accountability structure that Congress has the power to address.

Several witnesses highlighted specific instances that illustrate the gravity of the situation. One testimony detailed the tragic experience of a mother who received a transplanted liver that contained aggressive, undetected cancer, ultimately leading to her death. Despite rigorous screening protocols for recipients, the donor in this case, who was on life support for an extended period, was apparently not adequately screened for malignancy, with cancer reportedly discovered only after the transplant procedure. Another former OPO employee recounted a case where a patient, believed to be organ dead, reportedly regained consciousness before organ recovery procedures began, with concerns that the OPO may have misled the family and disregarded medical standards to advance its own metrics and financial incentives.

On November 3, transplant surgeons informed us that the donor liver contained high grade metastatic cancer that was not reported on the donor records from UNOS, but was discovered by the transplant hospital barns after transplant procedure was completed. We were informed this was a very deadly form of cancer, and if it were to spread, she wouldn’t be eligible for treatment. Our dreams were shattered. Fear and sadness washed over my mother’s face. She was relisted for transplant.

Heather Hollis Knuckles, speaking about her mother’s fatal liver and kidney transplant in 2022

The committee also heard about alleged misconduct at various OPOs, including accusations of Medicare fraud, research fraud, evidence manipulation, and failure to obtain proper donor consent. In some of the most disturbing allegations, whistleblowers claimed that patients who were not declared dead were subjected to organ recovery procedures, and that documentation was altered to conceal these events. Concerns were also raised about the misuse of taxpayer funds, with OPOs allegedly transferring significant sums to related organizations and engaging in excessive spending on non-patient care related activities.

After I came forward as a whistleblower, the Health Resources and Services Administration launched an investigation into my former employer. In just 89 days, there were 103 cases in which the organ donation process was initiated in error. What is even more frightening is that the investigation only examined cases in which the patient survived. We have no way of knowing how many times organs may have been recovered from patients who would have otherwise lived.

Nyckolleta (Nycki) Martin, Former OPO Employee

These revelations have underscored a critical need for enhanced transparency and accountability within the organ donation system. Lawmakers emphasized that OPOs, as federally designated monopolies entrusted with a life-saving mission, must be held to the highest standards of public trust. The current oversight structure, according to testimonies, is insufficient to prevent abuses and protect the public.

Furthermore, the disparities in organ transplantation rates among different racial and socioeconomic groups were also brought to light. Witnesses noted that communities of color often face delayed referrals, reduced access to transplant centers, and inconsistent communication from OPOs, impacting their ability to receive life-saving transplants. This raises critical questions about equity within the system.

The health insurance landscape was also discussed as a crucial factor impacting organ transplantation. Experts warned that the expiration of enhanced premium tax credits for health insurance plans could lead to millions of Americans losing coverage, making it more difficult for potential transplant recipients to secure and maintain the continuous insurance required by transplant centers. This could further exacerbate existing disparities and negatively impact transplant outcomes.

In response to these allegations, the committee is exploring policy options to reform the OPO certification process, implement penalties for violations of regulations, and improve data transparency for better oversight. The overarching goal is to restore public trust in organ donation, ensure ethical practices, and prioritize patient safety above all else. The committee stressed that accountability for OPOs is not merely a procedural matter, but a fundamental necessity for saving lives and honoring the generosity of organ donors and their families.

Article by Ken Buckler, based upon information from the U.S. House Committee on Ways & Means.

---